Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Cybin Inc (CYBN) Message Board

Study Finds That Plant-Based Diets Lower Risk of D

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 341
(Total Views: 148)
Posted On: 04/18/2022 5:37:35 PM
Avatar
Posted By: NetworkNewsWire
Study Finds That Plant-Based Diets Lower Risk of Developing Type 2 Diabetes

A new study has found that consuming a healthy plant-based diet of legumes, nuts, vegetables, fruits and coffee is linked to a lower risk of developing type 2 diabetes. Healthy plant-based diets are rich in high-quality foods such as whole grains, vegetables and fruits. These diets have been linked to a lower risk of type 2 diabetes.

Type 2 diabetes presents a major threat to health across the globe given that more than 90% of people with diabetes suffer from type 2 diabetes. Diabetes is mainly caused by unhealthy diets and genetic predisposition as well as being obese or overweight and other lifestyle factors, including not exercising.

Over the last 20 years, the prevalence of this chronic illness globally has increased significantly, with figures showing that between 2000 and 2019, cases rose to 450 million from 150 million. Projections show that by 2045, this figure will have risen to about 700 million.

The researchers’ objective was to identify metabolite profiles associated with various pant-based diets and look into potential links between the risk of developing type 2 diabetes and these profiles. A metabolite is a substance produced or used by the chemical processes in a living being. It includes the broad number of compounds found in diverse foods and the variety of molecules that are created because these compounds are used up by the body.

For their study, the researchers carried out an analysis of the dietary intake and samples of blood plasma gathered from more than 10,000 participants from certain cohorts. Each participant was required to complete a food frequency questionnaire, which was used to measure their adherence to the following plant-based diets: an unhealthy plant-based diet index, a healthy plant-based diet index and an overall plant-based diet index.

Diet indices were based off of every individual’s intake of these food groups: animal foods (meat, fish/seafood, eggs, dairy, animal fats and miscellaneous animal-based foods); unhealthy plant foods (sweets/desserts, sugar-sweetened beverages, potatoes, fruit juices and refined grains); and healthy plant foods (coffee/tea, vegetable oils, legumes, nuts, vegetables, fruits and whole grains).

The researchers determined between unhealthy and healthy plant foods according to their link with type 2 diabetes, particular cancers, cardiovascular disease and other conditions, including hypertension and obesity.

They discovered that the participants who were diagnosed with this form of diabetes consumed less healthy plant-based foods in addition to being more likely to have higher cholesterol levels and hypertension, be less physically active, have a family history of diabetes, and use cholesterol and blood pressure drugs.

This study was carried out by researchers in the Department of Nutrition at the Harvard T.H. Chan School of Public Health. This study, which was led by Professor Frank Hu, had its findings published in “Diabetologia.”

Diet seems to have a connection to lots of health conditions, including mental health disorders, which are growing to epidemic levels. Fortunately, several companies, including Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), are focused on addressing the need for superior therapeutics to combat the mental health crisis currently escalating at an alarming rate.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer





(0)
(0)




Cybin Inc (CYBN) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us